Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The retrospective cohort study, GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer, published in the August 2025 edition of Oncology , 3 was based on data from 116 patients with a breast cancer diagnosis prescribed GLP-1 RAs at the Memorial Sloan Kettering Cancer Center, from 2015 to 2023
Description Description: Stable Tartrate form to help support a lean muscular body
Retatrutide is still investigational, so it should not be described as FDA-approved or as having an established safety profile for routine prescribing
Understanding what's driving your hunger, whether it's your dose, timing, food choices, or other factors, is the first step toward finding the right solution
Zhang L, Zhang L, Li L, Hlscher C (2018) Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinsons disease mouse model
